Plunkett Research Online: Pieris Pharmaceuticals

PIERIS PHARMACEUTICALS (PIRS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of mol.....


PIERIS PHARMACEUTICALS

Ticker: PIRS
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 49 81611411400
Fax: 49 81611411444
Address: Lise-Meitner-Strasse 30
Munich, 85354 Germany

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of mol.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture